Peru Pharmaceuticals & Healthcare Report Q3 2016 - New Study Released

The presidential election result will maintain the attractiveness of Peru's pharmaceutical and healthcare sector. A Fujimori administration will further bolster Peru's business environment and encourage increasing investment in Peru's pharmaceutical manufacturing sector. Government commitment to healthcare will continue to improve domestic pharmaceutical consumption.

Headline Expenditure Projections

Pharmaceuticals: PEN4.98bn (USD1.56bn) in 2015 to PEN5.32bn (USD1.61bn) in 2016; +6.8% in local currency terms and 3.0% in US dollar terms. Forecast unchanged from previous quarter.
Healthcare: PEN34.9bn (USD11.0bn) in 2015 to PEN38.5bn (USD11.7bn) in 2016; +10.0% in local currency terms and 6.2% in US dollar terms. Forecast revised upwards from previous quarter.

Full Report Details at
- http://www.fastmr.com/prod/1191651_peru_pharmaceuticals.aspx?afid=301

Risk/Reward Index

In BMI's Risk/Reward Index (RRI) for Q316, Peru has maintained its position as ninth out of the 19 markets surveyed in the Americas matrix. Peru's Reward scores are viewed as being less favourable than the regional averages, while its risk scores are slightly above average. A small market size and a deficient intellectual property environment are some of the major drawbacks to involvement in Peru by foreign companies. Nevertheless, favourable trade deals with its neighbours as well as the US, combined with Fujimori's array of progressive reforms and push for increased foreign investment, will ensure Peru is still seen as a solid longer-term prospect to foreign investors, on account of the expected healthcare market development and economic growth.

Latest Updates

In May 2016, Quicorp, one of Peru's largest healthcare and pharmaceutical companies, acquired the Arcangel pharmacy chain, which included 340 stores. The acquisition brings Quicorp's total number of stores under its various brands in Peru to over 1,000. However InkaFarma controls a larger share of the market in terms of sales at its 848 stores as of last September.

In June 2016, Peru's Ministry of Health (MINSA) activated quarantine-like procedures (cerco epidemico) to prevent a national epidemic upon identifying indigenous cases of the Zika virus. The quarantine has helped the health ministry officials to identify new indigenous cases of Zika.

BMI Economic View

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)